AGL 5.51 Increased By ▲ 0.11 (2.04%)
ANL 8.49 Decreased By ▼ -0.30 (-3.41%)
AVN 75.73 Decreased By ▼ -0.43 (-0.56%)
BOP 5.21 Increased By ▲ 0.04 (0.77%)
CNERGY 4.42 Decreased By ▼ -0.06 (-1.34%)
EFERT 81.53 Increased By ▲ 0.43 (0.53%)
EPCL 49.54 Increased By ▲ 0.54 (1.1%)
FCCL 12.68 Decreased By ▼ -0.02 (-0.16%)
FFL 5.52 Decreased By ▼ -0.07 (-1.25%)
FLYNG 6.74 Decreased By ▼ -0.24 (-3.44%)
FNEL 4.64 Increased By ▲ 0.01 (0.22%)
GGGL 8.45 Decreased By ▼ -0.14 (-1.63%)
GGL 13.85 Decreased By ▼ -0.21 (-1.49%)
HUMNL 6.03 Increased By ▲ 0.53 (9.64%)
KEL 2.56 Decreased By ▼ -0.04 (-1.54%)
LOTCHEM 27.62 Decreased By ▼ -0.09 (-0.32%)
MLCF 23.75 Increased By ▲ 0.07 (0.3%)
OGDC 71.22 Decreased By ▼ -0.23 (-0.32%)
PAEL 15.16 Decreased By ▼ -0.04 (-0.26%)
PIBTL 4.87 Decreased By ▼ -0.04 (-0.81%)
PRL 15.86 Increased By ▲ 0.06 (0.38%)
SILK 1.09 Increased By ▲ 0.04 (3.81%)
TELE 8.84 Decreased By ▼ -0.15 (-1.67%)
TPL 7.08 Decreased By ▼ -0.08 (-1.12%)
TPLP 19.20 Decreased By ▼ -0.02 (-0.1%)
TREET 20.87 Decreased By ▼ -0.27 (-1.28%)
TRG 136.73 Decreased By ▼ -0.02 (-0.01%)
UNITY 16.54 Decreased By ▼ -0.26 (-1.55%)
WAVES 9.16 Increased By ▲ 0.06 (0.66%)
WTL 1.34 Decreased By ▼ -0.03 (-2.19%)
BR100 4,158 Decreased By -27.7 (-0.66%)
BR30 15,339 Decreased By -127.2 (-0.82%)
KSE100 41,652 Decreased By -167.7 (-0.4%)
KSE30 15,380 Decreased By -68.1 (-0.44%)
Follow us

WASHINGTON: The United States on Friday authorized Pfizer and Moderna Covid vaccine boosters to all people aged 18 and older, the Food and Drug Administration (FDA) said.

Boosters were previously available to the immune compromised, over 65s, people at high risk of severe disease and people in high risk occupations.

The decision "helps to provide continued protection against Covid-19, including the serious consequences that can occur, such as hospitalization and death," said acting FDA commissioner Janet Woodcock.

"This emergency use authorization comes at a critical time as we enter the winter months and face increasing Covid-19 case counts and hospitalizations across the country," added Moderna CEO Stephane Bancel.

Austria imposes full lockdown, Germany may follow, as Covid grips Europe

The FDA said it based its decision on strong immune response data from hundreds of people dosed with the two vaccines.

Pfizer's vaccine is dosed at 30 micrograms, the same as the primary series, while Moderna's is 50 micrograms, half the primary series -- but this was not cited by the FDA as data used to make its decision.

Pfizer also carried out a clinical trial involving 10,000 people aged over 16 which found the booster restored vaccine efficacy to 95 percent.

Moderna says its COVID-19 vaccine protective, safe in young children

The Centers for Disease Control and Prevention will hold a meeting later Friday to discuss clinical recommendations for who should now seek a vaccine.

Both companies are conducting post authorization studies to assess the risks of myocarditis, or heart inflammation, which is more elevated in younger males.

Comments

Comments are closed.

US authorizes Covid boosters for all over 18s

Pakistan seeking $4.2bn from Saudi Arabia: reports

Will take action if terrorists regroup in Afghanistan: US State Department

Arshad Sharif killing: SC directs JIT to submit progress report every two weeks

IHC bars FIA from arresting Suleman Shehbaz upon return from UK

Rupee continues to depreciate, settles at 224.37 against US dollar

Roshan Digital Account: monthly inflow lowest since Dec 2020, clock in at $141mn in Nov

Another audio, purportedly of Bushra Bibi discussing ‘sale of watches’, surfaces

Modi’s party set for landslide election win in India’s Gujarat state

China buys Russian oil at multi-month low discounts, brushes off price cap

Israeli forces kill 3 Palestinians in West Bank: Palestinian ministry